|
1
|
Sterz G: Polymyositis. Berl Klin
Wochenschr. 53(489)1916.
|
|
2
|
Bezecny R: Dermatomyositis. Arch Dermat
Syph. 171:242–251. 1935.
|
|
3
|
Buchbinder R, Forbes A, Hall S, Dennett X
and Giles G: Incidence of malignant disease in biopsy-proven
inflammatory myopathy. A population-based cohort study. Ann Intern
Med. 134:1087–1095. 2001.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Stockton D, Doherty VR and Brewster DH:
Risk of cancer in patients with dermatomyositis or polymyositis,
and follow-up implications: A Scottish population-based cohort
study. Br J Cancer. 85:41–45. 2001.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Hill CL, Zhang Y, Sigurgeirsson B, Pukkala
E, Mellemkjaer L, Airio A, Evans SR and Felson DT: Frequency of
specific cancer types in dermatomyositis and polymyositis: A
population-based study. Lancet. 357:96–100. 2001.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Qiang JK, Kim WB, Baibergenova A and
Alhusayen R: Risk of malignancy in dermatomyositis and
polymyositis. J Cutan Med Surg. 21:131–136. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Azuma K, Yamada H, Ohkubo M, Yamasaki Y,
Yamasaki M, Mizushima M and Ozaki S: Incidence and predictive
factors for malignancies in 136 Japanese patients with
dermatomyositis, polymyositis and clinically amyopathic
dermatomyositis. Mod Rheumatol. 21:178–183. 2011.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Fiorentino DF, Chung LS, Christopher-Stine
L, Zaba L, Li S, Mammen AL, Rosen A and Casciola-Rosen L: Most
patients with cancer-associated dermatomyositis have antibodies to
nuclear matrix protein NXP-2 or transcription intermediary factor
1γ. Arthritis Rheum. 65:2954–2962. 2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Trallero-Araguás E, Rodrigo-Pendás JÁ,
Selva-O'Callaghan A, Martínez-Gómez X, Bosch X, Labrador-Horrillo
M, Grau-Junyent JM and Vilardell-Tarrés M: Usefulness of anti-p155
autoantibody for diagnosing cancer-associated dermatomyositis: A
systematic review and meta-analysis. Arthritis Rheum. 64:523–532.
2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Taki E, Shimizu M, Soeda Y, Shirai M and
Muro Y: Anti-TIF1-γ-positive young adult dermatomyositis with germ
cell tumour. Eur J Dermatol. 26:623–624. 2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Airio A, Kautiainen H and Hakala M:
Prognosis and mortality of polymyositis and dermatomyositis
patients. Clin Rheumatol. 25:234–239. 2006.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Fife RS, Williams S and Eyanson S:
Dermatomyositis associated with treated testicular carcinoma. J
Rheumatol. 11:397–398. 1984.PubMed/NCBI
|
|
13
|
Barker RA, Currie DC, Horwich A and Spiro
SG: Metastatic non-seminomatous germ cell tumour and
dermatomyositis. Postgrad Med J. 66:59–60. 1990.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Clayton AJ and Mead GM: Germ cell cancer
and dermatomyositis. Clin Oncol (R Coll Radiol). 10:56–58.
1998.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Hayami S, Kubota Y, Sasagawa I, Suzuki H,
Nakada T and Motoyama T: Dermatomyositis associated with
intratubular germ cell tumor and metastatic germ cell cancer. J
Urol. 159:2096–2097. 1998.PubMed/NCBI
|
|
16
|
Ishizawa T, Mitsuhashi Y and Kondo S:
Dermatomyositis associated with testicular tumour with elevation of
serum lactate dehydrogenase (LDH) isoenzyme-1. Acta Derm Venereol.
79(167)1999.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Di Stasi SM, Poggi A, Giannantoni A and
Zampa G: Dermatomyositis associated with testicular germ cell
cancer. J Urol. 163(240)2000.PubMed/NCBI View Article : Google Scholar
|
|
18
|
von Heyden B, Kliesch S and Nashan D: Re:
Dermatomyositis associated with testicular germ cell cancer. J
Urol. 164(2030)2000.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Vattemi G, Tonin P, Martignoni G, Filosto
M, Marchioretto F, Rizzuto N and Tomelleri G: Dermatomyositis and
retroperitoneal germ cell cancer. Eur Neurol. 45:52–53.
2001.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Yoshinaga A, Hayashi T, Ishii N, Ohno R,
Watanabe T and Yamada T: Successful cure of dermatomyositis after
treatment of nonseminomatous testicular cancer. Int J Urol.
12:593–595. 2005.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Curiel RV, Brindle KA, Kressel BR and Katz
JD: Dysphagia after testicular cancer. Arthritis Rheum.
52(3712)2005.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Singhal N, Hissaria P, Joshi R and Nayagam
S: Inflammatory myopathy and cancer: Rare association of seminoma
testes and polymyositis. Intern Med J. 38:295–297. 2008.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Dourmishev LA, Popov JM and Rusinova D:
Paraneoplastic dermatomyositis associated with testicular cancer: A
case report and literature review. Acta Dermatovenerol Alp
Pannonica Adriat. 19:39–43. 2010.PubMed/NCBI
|
|
24
|
Tan E, Young D, McLaren B and Wright A:
Early-stage testicular cancer: A rare association with
dermatomyositis. Australas J Dermatol. 51:139–141. 2010.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Kamei J, Kyono Y, Yamada Y, Shinohara M
and Homma Y: Life-threatening polymyositis associated with
non-seminomatous testicular cancer: A case report. Hinyokika Kiyo.
58:361–364. 2012.PubMed/NCBI(In Japanese).
|
|
26
|
Norrenberg S, Gangji V, Del Marmol V and
Soyfoo MS: Diffuse muscular pain, skin tightening, and nodular
regenerative hyperplasia revealing paraneoplastic amyopathic
dermatomyositis due to testicular cancer. Case Rep Rheumatol.
2012(534236)2012.PubMed/NCBI View Article : Google Scholar
|
